Skip to main content
Article
Very late presentation of fulminant myocardial immune-related toxicity in a patient on pembrolizumab
Journal of the American College of Cardiology
  • Mahmoud Ali, Advocate Aurora Health
  • Marc Atzenhoefer, Advocate Aurora Health
  • Kevin Bodker, Advocate Aurora Health
  • Tarek Ajam, Advocate Aurora Health
  • Daniel Johnsrud, Advocate Aurora Health
  • Zeinab Saleh, Advocate Aurora Health
  • Adil S Wani, Advocate Aurora Health
  • Patrycja Galazka, Advocate Aurora Health
  • Tanvir Bajwa, Advocate Aurora Health
  • M Fuad Jan, Advocate Aurora Health
Affiliations

Aurora Cardiovascular and Thoracic Services, Aurora St. Luke’s/Aurora Sinai Medical Centers,

Publication Date
3-24-2020
Presentation Notes
Poster presented at: ACC.20 World Congress of Cardiology; March 30, 2020.
Document Type
Abstract
Citation Information

Ali M, Atzenhoefer M, Bodker K, et al. Very late presentation of fulminant myocardial immune-related toxicity in a patient on pembrolizumab. J Am Coll Cardiol. 2020;75(S11):3273.